MedOncMD

To provide the information your oncologist is not telling you or doesn't have the time to!

FDA Approves Inavolisib for Endocrine-Resistant Advanced Breast Cancer: A New Option for PIK3CA-Mutated Patients

On October 10, 2024, the FDA approved a new and promising treatment for patients with advanced breast cancer: inavolisib (Itovebi), in combination with palbociclib and fulvestrant. This new approval offers fresh hope for patients with endocrine-resistant, PIK3CA-mutated, hormone receptor (HR)-positive, and HER2-negative breast cancer, especially those whose disease has progressed after endocrine therapy. The approval also includes the FoundationOne Liquid CDx assay, a diagnostic test used to …

Read On »

A Promising New Treatment for Metastatic Breast Cancer: Exploring Bria-IMT™ and Its Impact

A Promising New Treatment for Metastatic Breast Cancer: Exploring Bria-IMT™ and Its Impact When battling metastatic breast cancer, finding effective treatment options can feel like an uphill battle, especially when cancer has spread to other areas, like the brain. But new hope is on the horizon. A groundbreaking therapy called Bria-IMT™ is showing promising results in clinical …

Read On »

Targeting Cancer at Its Core: Unlocking the Power of Biomarker-Driven Therapies in Breast Cancer Treatment

Breast Cancer Treatment October is Breast Cancer Awareness Month, a time dedicated to spreading knowledge, supporting research, and empowering patients and healthcare providers alike. Throughout the month, we’ll explore various critical aspects of breast cancer care. In this post, we focus on the current role of targeted therapies in treatment and encourage both patients and …

Read On »

New Insights on Bladder Cancer Treatment: A Study on Lymphadenectomy and Its Impact

Bladder Cancer Bladder cancer is one of the most common cancers in the world. About 81,000 new cases are diagnosed annually in the U.S. alone. While it’s more common in men, it affects thousands of women as well. Most bladder cancers are urothelial carcinomas. If caught early, they can often be treated successfully. However, for patients with muscle-invasive …

Read On »

Immunotherapy in Breast Cancer: A Modern Approach to Treatment

October is Breast Cancer Awareness Month, a time dedicated to spreading knowledge, supporting research, and empowering patients and healthcare providers alike. Throughout the month, we’ll explore various critical aspects of breast cancer care. In this post, we focus on the current role of immunotherapy in treatment and encourage both patients and providers to consider clinical …

Read On »

A Promising New Treatment for Chronic Myeloid Leukemia: What You Should Know About Asciminib

A recent New England Journal of Medicine study introduces asciminib, a new treatment for Chronic Myeloid Leukemia (CML) that shows improved effectiveness and fewer side effects compared to current therapies. This post will explain the study’s findings and what they mean for patients and caregivers, highlighting how asciminib could offer a better option for those newly diagnosed with …

Read On »

Advancing Breast Cancer Prevention: A Comprehensive Oncologist’s Perspective

October: Breast Cancer Awareness Month October is Breast Cancer Awareness Month, a time dedicated to raising awareness, supporting research, and encouraging early detection. In honor of this important cause, we’re highlighting crucial preventive measures and ways to reduce breast cancer risk. This article also connects to the ongoing efforts to support breast cancer research, with …

Read On »

✕